Q13153 (PAK1_HUMAN) Homo sapiens (Human)

Serine/threonine-protein kinase PAK 1 UniProtKBInterProInteractive Modelling

545 aa; Sequence (Fasta) ; (Isoform 2; ) Identical sequences: Homo sapiens: A0A024R5P0; Pongo abelii: A0A2J8V0U5; Pan troglodytes: K7DSU6; Gorilla gorilla gorilla: G3RY99; Nomascus leucogenys: A0A2I3H6Y7

Sequence Features

 389Proton acceptor.
 131Y -> C (in IDDMSSD; gain of function; enhanced PAK1 kinase activity and significantly reduced homodimerization). VAR_081554
 429Y -> C (in IDDMSSD; gain-of-function; enhanced PAK1 kinase activity and significantly reduced homodimerization). VAR_081555
 515L -> V (in dbSNP:rs35345144). VAR_051654 dbSNP
 276-284ATP.
 345-347ATP.
 74-132CRIB domain
IPR000095PF00786
 270-521Protein kinase domain
IPR000719PF00069

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRangeDownloadAssess
CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE KINASE PAK1 Heteromer
Q13153;
28×IOD;1f3m78-542
'Serine/threonine-protein kinase PAK1 complexed with a dibenzodiazepine: identification of an all... Heteromer
Q13153;
4PV;GOL;4zlo250-543
Back pocket flexibility provides group-II PAK selectivity for type 1 kinase inhibitors Heteromer
Q13153;
2OL;4o0t251-542
'Crystal structure of human RAC3 in complex with CRIB domain of human p21-activated kinase 1 (PAK1)' Heteromer
Q13153; P60763;
GCP;MG;GOL;2qme74-97
beta PIX-SH3 complexed with an atypical peptide from alpha-PAK Heteromer
Q14155;
1zsg183-204
Pak1 peptide bound LC8 Heteromer
Q13153; Q24117;
3dvp213-221
Structure of unphosphorylated PAK1 kinase domainhomo-2-mer MG;ANP;3q4z250-545
Back pocket flexibility provides group-II PAK selectivity for type 1 kinase inhibitorshomo-2-mer 7KC;4o0r249-542
Crystal structure of PAK1 in complex with an inhibitor compound 5monomer 59N;5dew250-544
Crystal structure of PAK1 in complex with an inhibitor compound G-5555monomer 59T;5dey250-544
Crystal structure of P21-activated kinase 1 (PAK1) in complex with compound 9monomer 6BZ;5ime251-545
Crystal structure of PAK1 kinase domain with the ruthenium phthalimide complexmonomer 0H2;4daw249-542
Crystal structure of PAK1 kinase domain with ruthenium complex lambda-FL172monomer FLL;3fxz249-541
Crystal Structure of PAK1 kinase domain with two point mutations (K299R, T423E)monomer 1yhv249-541
Crystal Structure of PAK1 kinase domain with one point mutations (K299R)monomer 1yhw249-541
Structure of phosphorylated PAK1 kinase domainmonomer 3q52250-542
PAK1 complex with ST2001monomer 1ST;2hy8249-541
Crystal structure of PAK1 kinase domain in complex with FRAX597 inhibitormonomer XR1;CL;4eqc249-541
Crystal structure of PAK1 in complex with an inhibitor compound FRAX1036monomer DMS;59U;5dfp249-541
Crystal structure of PAK1 kinase domain with ruthenium complex DW1monomer DW1;3fy0249-541
Crystal structure of the kinase domain of human PAK1 in complex with compound 15monomer 2K0;4p90250-542
Crystal structure of P21 activated kinase 1 in complex with an inhibitor compound 4monomer 4T3;SO4;4zy4249-541
Structure of phosphorylated PAK1 kinase domain in complex with ATPmonomer MG;ATP;3q53250-541
Crystal structure of P21-activated kinase 1 in complex with an inhibitor compound 29monomer 4T6;SO4;4zy6251-542
P21-activated kinase 1 in complex with a 4-azaindole inhibitormonomer C7Y;SO4;6b16251-542
Crystal Structure of p21-activated kinase 1 in complex with an inhibitor compound 17monomer SO4;4T5;4zy5251-542
'PAK1 in complex with (S)-N-(tert-butyl)-3-((2-chloro-5-ethyl-8-fluoro-dibenzodiazepin-11-yl)amin...monomer 4OR;4zjj249-539
PAK1 in complex with 2-chloro-5-ethyl-8-fluoro-11-(4-methylpiperazin-1-yl)-dibenzodiazepinemonomer 4OQ;4zji254-542
Pak1 in complex with bis-anilino pyrimidine inhibitormonomer IPV;5kbq254-542
Pak1 in complex with 7-azaindole inhibitormonomer IPW;5kbr255-542

Homology models built on isoform sequence

Isoform #Oligo-stateLigandsQMEANTemplateRangeSeq id (%)ReportDownloadAssess
2monomerZN;-3.824wb7.2.A195-509
27.51
2monomer4PV;0.454zlo.1.A250-525
97.47